VIS, Inc. Receives Its Medical Device License Through Health Canada

Revolutionizing Laser Eye Correction
Opti-K™ is a groundbreaking, noninvasive laser-based procedure designed to address vision issues caused by presbyopia, hyperopia, myopia, and age-related macular degeneration (AMD).
Team

George Aubrey

Chief Executive Officer

Don Schwall

Chief Commercial Officer

Dr. Harry Glen

MD - Chief Medical Officer
Steve Klyce PhD

Dr. Stephen Klyce

PhD FAVRO - Scientific Director
Marguerite McDonald MD

Dr. M. McDonald

MD FACS - Key Opinion Leader

Jerry Rein

BSc - Director of Engineering

RQC Partners

Global GxP Advisor

Total Diversity

CRO - Clinical Trial Management

Potomac Photonics

Engineering and Manufacturing
Contact Us

Learn More About VIS and Opti-K™

Well, that's not 20/20...

At VIS, we understand that sight is one of our most precious senses—the one people fear losing the most. Our mission is to commercialize and scale proprietary laser-based optical systems, empowering ophthalmologists to provide safe, fast, and affordable treatments that deliver exceptional results.

DISCLAIMER: The VIS Optimal Keratoplasty (Opti-K™) System is an investigational device, and it is not available for sale or use in the United States.

VIS, Inc.
2800 Dallas Parkway, Suite 100
Plano, TX 75093
United States of America
Monday - Friday 8:00 AM - 6:00 PM
info@viscorrect.com
+1 561 819 8300